Frank R. Oakes insider trades: Edesa Biotech (EDSA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frank reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2021 | EDSA | ↓ Sell | 6,165 | $7.25 | $45K | Direct | Feb 18, 2021 (0d) |
| Feb 18, 2021 | EDSA | ↓ Sell | 1,827 | $7.25 | $13K | By Trust | Feb 18, 2021 (0d) |
| Sep 11, 2019 | EDSA | ↓ Sell | 1,809 | $5.72 | $10K | Direct | Sep 13, 2019 (2d) |
| Mar 6, 2019 | SBOT | ↓ Sell | 4,000 | $1.25 | $5K | Direct | Mar 11, 2019 (5d) |
| Oct 12, 2018 | SBOT | ↓ Sell | 3,000 | $1.31 | $4K | Direct | Oct 12, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EDSA insiders
Open-market trades in the last 12 months
About Frank R. Oakes's insider trades
Frank R. Oakes is an insider at Edesa Biotech (EDSA). Since Oct 12, 2018, Frank has reported no open-market purchases and 5 sales worth $77K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), option exercises (3 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EDSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.